Form 4: SERA CSO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


SERA PROGNOSTICS' Chief Scientific Officer, John J. Boniface, sold 1,517 shares of Class A Common Stock to cover tax withholding obligations from RSU vesting.

Summary

  • John J. Boniface, Chief Scientific Officer of SERA PROGNOSTICS, INC. (SERA), reported a sale of 1,517 shares of Class A Common Stock.
  • The transaction occurred on March 11, 2026, at a weighted average price of $2.04 per share.
  • The shares were sold as part of a block trade with prices ranging from $1.90 to $2.30.
  • The sale was non-discretionary, mandated by the issuer's policy to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
  • Following this transaction, Mr. Boniface beneficially owns 145,842 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale was non-discretionary and for tax purposes, indicating no change in the insider's sentiment towards the company's future.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

  • The sale represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ('RSUs').
  • The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by 'sell to cover' transactions and does not represent a discretionary transaction by the Reporting Person.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and routine occurrence for executives receiving equity compensation, particularly restricted stock units. They typically do not reflect a change in management's confidence in the company's future prospects but rather a mechanism to satisfy tax liabilities upon vesting.

Stakeholder Impact

  • Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in insider confidence.

Key Dates

DateDescription
03/11/2026Date of transaction (sale of Class A Common Stock)
03/12/2026Date of filing of the Statement of Changes in Beneficial Ownership

Keywords

SERA PROGNOSTICS, SERA, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Chief Scientific Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.